NewBiologix - Crunchbase Company Profile & Funding

Q: Where is NewBiologix's headquarters?

NewBiologix is located in Epalinges, Vaud, Switzerland.

Q: Who invested in NewBiologix?

NewBiologix has 3 investors including Nicolas Mermod And Igor Fish.

Q: When was the last funding round for NewBiologix?

NewBiologix closed its last funding round on obfuscated from a Series A round.

Q: How much funding has NewBiologix raised to date?

NewBiologix has raised obfuscated.

Overview

NewBiologix

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About NewBiologix

CB Rank

43936

NewBiologix operates as a technology innovation company.

Founded

obfuscation

Private

Series A

Epalinges, Vaud, Switzerland

11-50

www.newbiologix.com/

Biotechnology

Health Care

Life Science

Medical

Funding Rounds

Series A

OBF

obfuscation

Details

Legal Name

NewBiologix SA

Operating Status

Active

Company Type

For Profit

About the Company

NewBiologix operates as a technology innovation company, develops a proprietary and breakthroughDNA integration platform for the advanced engineering of human and mammaliancell lines.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Xcell™ Eng-HEK293 Cell Line

A suspension HEK293 cell line engineered for stable, high-yield production of recombinant adeno-associated viruses (rAAV) used in gene therapy.

Xcell™ rAAV Production and Analytics Platform

A platform combining engineered cell lines and analytical tools for scalable production and quality control of recombinant adeno-associated viruses (rAAV) for gene therapy.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - NewBiologix	3	obfuscated obfuscation	Recipharm Venture Fund	Series A
obfuscated obfuscation	Series A - NewBiologix	3	obfuscated obfuscation	Recipharm Venture Fund	Series A
obfuscated obfuscation	Series A - NewBiologix	3	obfuscated obfuscation	Recipharm Venture Fund	Series A
obfuscated obfuscation	Series A - NewBiologix	3	obfuscated obfuscation	Recipharm Venture Fund	Series A
obfuscated obfuscation	Series A - NewBiologix	3	obfuscated obfuscation	Recipharm Venture Fund	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - NewBiologix	3	obfuscated obfuscation	Recipharm Venture Fund	Series A
obfuscated obfuscation	Series A - NewBiologix	3	obfuscated obfuscation	Recipharm Venture Fund	Series A
obfuscated obfuscation	Series A - NewBiologix	3	obfuscated obfuscation	Recipharm Venture Fund	Series A
obfuscated obfuscation	Series A - NewBiologix	3	obfuscated obfuscation	Recipharm Venture Fund	Series A
obfuscated obfuscation	Series A - NewBiologix	3	obfuscated obfuscation	Recipharm Venture Fund	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Nicolas Mermod	—	Series A - NewBiologix	—
Nicolas Mermod	—	Series A - NewBiologix	—
Nicolas Mermod	—	Series A - NewBiologix	—
Nicolas Mermod	—	Series A - NewBiologix	—
Nicolas Mermod	—	Series A - NewBiologix	—